
Return to Inside Out Home PageCalgary, Alberta, in June of nineteen ninety-seven was a great place for a Canadian ostomate to be.
U.O.A. Canada held it's first general meeting on Canadian soil on Sunday the fifteenth. At that meeting, delegates from Canadian U.O.A. chapters voted 42 to 2 to support the formation of a separate Canadian association and to disaffiliate from the United Ostomy Association, a United States based organization.
The United Ostomy Association, from its earliest days, has been a joint United States and Canadian association. Without its help and support over the years, Canadian ostomates would not have achieved the great gains in quality of life that have been made since the U.O.A. was formed. We, as Canadian ostomates, realize how much the United Ostomy Association has done for us and we shall be forever grateful. They have helped us get into a position where we can test our wings and fly, as an independent, uniquely Canadian organization. Thank you United Ostomy Association - we'll stay in touch.
Here in Winnipeg we shall part ways with our friends in the North Central Conference of the U.O.A. We will stay in touch through continuing to exchange newsletters and hope to be invited to the next North Central Regional Conference.
After the historic U.O.A. Canada meeting on Sunday, the International Ostomy Association's 9th World Congress took place. Maria Siegl, Chairman of the Congress Organizing Committee and President of U.O.A. Canada, and her eager crew of volunteers put on an excellent conference. It was fitting that Canada hosted the occasion as U.O.A. Canada got to take its place in the world ostomy community the day after becoming an independent body.
There were thirty-five countries represented at the Congress, ranging from Australia to Norway, China to Israel, Brazil to Slovakia. French and Spanish translation was provided live during the entire event.
Hearing about ostomates' struggles and triumphs from around the world was a moving experience. The fact that every association, including the I.O.A., is volunteer-based, and that the entire conference was put on with no paid staff was an extraordinary revelation.
The foundation of all ostomy associations is "people caring about people". We are not members for the fame or fortune. We join initially, because we need support. Later we want to help others weather the same storm we did, to help them come sailing through the other side of it, into a second chance at life - hopefully with recognition of what a wonderful gift our ostomy has given us.
This magic is happening all around the world. I felt very grateful to be part of this global community for a few days at the Congress.
Editor
From the President's Desk
As I write this it is a glorious late August day, beautiful blue sky overhead, very light winds, temperature in the mid twenties. I must agree with a friend's comment from the other day, "I hope the weather stays like this for the next six months and then warms up a bit." However, we all know that this is not the case. I do hope all of you had a most enjoyable and refreshing summer.
When you receive this newsletter we will be well into September and another season of activities for the Winnipeg Ostomy Association.
United Ostomy Association of Canada Inc. An Independent Organization.
How did it happen?
In July all chapters across Canada were asked to officially affiliate with U.O.A. Canada. On the strength of the March vote, the executive of the W.O.A. has officially requested affiliation with U.O.A. Canada by filing an application form. At the same time, a letter of disaffiliation was sent from W.O.A. to U.O.A. Inc. in the U.S.A.. W.O.A. executive also decided to direct membership dues to U.O.A. Canada beginning with "D" quarter, 1997, the July to September quarter. By the end of "C" quarter, April to June, 1998, all W.O.A. membership dues will be directed to U.O.A. Canada.
Last winter the executive was working on revising the WOA constitution, but when it became apparent that change was in the making all was put on hold. That delay was fortunate as we have now received a set of by-laws, which we will have to incorporate onto our constitution in order to bring us in line with the U.O.A. Canada constitution.
The World Congress was a once in a lifetime event, challenging, enlightening, informative, and for some, one heck of a lot of fun! Over the next number of issues I will write more about the times we had in Calgary.
But, enough for now. See you all September 17th!
Dave Page, President.
By Dr. D.M. Carr, M.D., FRCP (C); Clinical Associate Professor of Medicine, Division of Gastroenterology, University of British Columbia; Active staff, Division of Gastroenterology, Vancouver Hospital.
Individuals who develop ulcerative colitis soon become aware that they have an increased risk of cancer of the bowel which may cause them unnecessary fear of developing cancer or the need to have the colon removed to prevent it.
Earlier reports suggested a relatively high incidence of cancer of the colon in patients with ulcerative colitis especially when the whole colon is involved and with increasing risk with duration of the disease. It was also thought that when colitis developed in childhood there was an increased risk of malignancy. In fact, it was felt by some that the risk of cancer was high enough to warrant "prophylactic" proctocolectomy in those at increased risk. Fortunately, more recent studies have not confirmed such a high incidence. However, they established an increased risk associated with the extent of the involvement of the colon and the length of time of having colitis. The risk of malignancy associated with onset of ulcerative colitis in childhood is due to the much longer duration of the disease.
With colitis involving most or all of the colon (universal or pancolitis), the statistical increased risk of cancer of the colon begins 10 years after onset, at which time it is estimated that there is about a 1% risk of cancer compared to a normal population. If the disease is left-sided the risk does not increase for another 10 years (1% risk at 20 years from onset). Persons with distal ulcerative colitis (proctosigmoiditis) are at little risk, probably not any greater than the general population.
The cumulative annual incidence of cancer of the colon means that there is a sharp increase in risk after 20 years of having universal ulcerative colitis and after 30 years of left sided disease. Since the majority of patients with ulcerative colitis have distal or left-sided disease the relative risk is quite small.
It is now recognized that Crohn's disease, in particular Crohn's colitis, has an increased incidence of cancer. The risk, however, is much less than that associated with ulcerative colitis. Because the risk is substantially less, it has not been recommended that these patients undergo surveillance investigation for cancer on a regular basis as is done for ulcerative colitis.
In people with ulcerative colitis it is important that colonoscopes be performed at some stage to confirm the diagnosis, determine the extent of involvement and plan management. Patients with universal colitis should begin surveillance colonoscopy at about 8 years from onset with the examinations done on a one to two yearly basis becoming more frequent with longer duration of disease. Those with left-sided disease normally start surveillance at fifteen years from onset, with examinations every 2-3 years. During a surveillance examination serial biopsies are taken throughout the colon. If there are any flat, raised "mass" lesions or other suspicious areas, they are extensively biopsied. If there is "flat mucosa" present, biopsies are taken at 10 cm intervals. A pathologist interpreting the biopsies should be knowledgeable in assessing "dysplasia".
Dysplasia, when present, is "low grade" or "high grade", depending upon the size and appearance of the nuclei in mucosal cells. This is equivalent to a "pap test". If low-grade dysplasia is present, more frequent follow-up examinations are done. If the changes are high grade, and especially if associated with raised lesions, there is a high probability of having or developing cancer with a need for operative removal of the entire colon and rectal mucosa. Active inflammation may cause dysplastic change within the cells and it may be necessary to aggressively treat the colitis with repeat colonoscopy and biopsies once in remission. Pseudopolyps are the consequence of active inflammation and do not become malignant. Those at risk must be followed appropriately because the risk of cancer is still present even when the colitis has been in long remission. In fact, about 50% of patients presently with cancer of the colon do so having had no symptoms of their colitis for many years.
Some patients are concerned because of the theoretical risk of malignancy from immunosuppressive drugs such as Azathioprine (Imuran) or 6-Mercaptopurine (6-MP). These drugs in lower doses act synergistically to reduce the need for corticosteroid drugs such as Prednisone, and thus reduce the side effects. In some patients with Crohn's disease, the immunosuppressive drugs have been used in higher doses as primary therapy. Since the use of immunosuppressive drugs tends to be long term, there may be suppression of the normal immune mechanisms in the body which help prevent development of cancer, especially lymphomas. Fortunately, there has been no evidence of any significant increased risk of malignancy related to immunosuppressive drugs, particularly when used in lower doses for "steroid sparing".
As with any concern, the best protection is prevention and this requires a common sense surveillance program in those persons with inflammatory bowel disease at increased risk of developing cancer.
Above article from Northwestern Society of Intestinal
Research, Issue No. 94 March/April '96
Via Abbotsford Ostomy News; Vancouver Ostomy Highlife, 9/96